(NATI, CLNO, PWRM, IMGN, PENN) Stock in Action by DrStockPick.com
Wednesday, June 15th, 2011National Instruments Corporation (Nasdaq:NATI) introduced the new NI Digital Video Analyzer, which automates a wide range of tests for the latest HDMI sources such as set-top boxes, Blu-ray Disc players and DVD players. The analyzer features configuration-based test steps that automate measurements of HDMI features including 3-D video, HDMI 1.4 protocol and picture quality analysis. With hardware based on the NI PXI Express platform and software designed for multicore computing, engineers can use the NI Digital Video Analyzer to achieve high-performance, high-precision measurements of HDMI content in a fraction of the time required by traditional video test solutions.
National Instruments Corporation manufactures and supplies measurement and automation products.
*******************************************************
Cleantech Transit, Inc. (CLNO)
Biomass is organic material made from plants and animals. Biomass contains stored energy from the sun. Plants absorb the sun’s energy in a process called photosynthesis. The chemical energy in plants gets passed on to animals and people that eat them. Biomass is a renewable energy source because we can always grow more trees and crops, and waste will always exist. Some examples of biomass fuels are wood, crops, manure, and some garbage.
When burned, the chemical energy in biomass is released as heat. If you have a fireplace, the wood you burn in it is a biomass fuel. Wood waste or garbage can is burned to produce steam for making electricity, or to provide heat to industries and homes.
Cleantech Transit, Inc. is in the business of producing and conserving power. They produce and sell clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. Cleantech Transit, Inc goal is to use innovative technologies to reduce electricity consumption and dependence on carbon based energy.
Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.
Cleantech Transit Inc. is pleased to provide additional details after achieving success on the 500 KW facilities and successfully moving past the interconnection testing stage.
Coming on the recent success at the 500KW facility in Merced, California this poises Phoenix Energy to become a leading developer of renewable biomass distributed generation plants that utilize local resources for local energy.
Currently there are two additional projects being pre-certified by Phoenix Energy in California. The projects are each projected to be 1 MW biomass gasification facilities that will provide both electricity and process heat energy. Each facility will provide enough electricity to power approximately 800 homes as well as process heat to be used in drying agricultural products. The projects are expected to complete by the end of 2012.
Cleantech will be providing details on the expecting closing date of its initial investment into Phoenix Energy in the coming weeks.
For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com
******************************************
Power3 Medical Products Inc. (PWRM)
Parkinson’s disease is a progressive neurological disorder that results from degeneration of neurons in a region of the brain that controls movement. This degeneration creates a shortage of the brain signaling chemical (neurotransmitter) known as dopamine, causing the movement impairments that characterize the disease.
Often, the first symptom of Parkinson’s disease is tremor (trembling or shaking) of a limb, especially when the body is at rest. The tremor often begins on one side of the body, frequently in one hand. Other common symptoms include slow movement (bradykinesia), an inability to move (akinesia), rigid limbs, a shuffling gait, and a stooped posture. People with Parkinson’s disease often show reduced facial expressions and speaks in a soft voice. Occasionally, the disease also causes depression, personality changes, dementia, sleep disturbances, speech impairments, or sexual difficulties. The severity of Parkinson’s symptoms tends to worsen over time.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
The NuroPro Blood Test of Power3 Medical Products, Inc is a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.
For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com
*******************************************************
Immunogen Inc. (Nasdaq:IMGN) announced positive clinical data with the Company’s IMGN901 (lorvotuzumab mertansine) product candidate as featured in an oral presentation (abstract #8013) at the ASCO 2011 Annual Meeting in Chicago. The data are from an ongoing Phase I trial assessing the compound used as part of a combination regimen for the treatment of multiple myeloma. IMGN901 is in development by ImmunoGen for the treatment of CD56-expressing cancers, which include small-cell lung cancer, multiple myeloma, Merkel cell carcinoma, and ovarian cancer.
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops its product candidates using its Targeted Antibody Payload (TAP) technology.
*******************************************************
Penn National Gaming Inc. (Nasdaq:PENN) announced that subject to customary regulatory approvals, Ameet Patel, 44, has been named General Manager of Hollywood Casino Columbus in Franklin County, Ohio, effective August 1, 2011. Mr. Patel currently serves as General Manager of Penn National’s Argosy Casino Hotel & Spa in Riverside, Missouri, a position he has held since October 2008. Penn National also announced that subject to customary regulatory approvals, John Chaszar, 48, currently the General Manager of Hollywood Casino Baton Rouge, will succeed Mr. Patel as General Manager of Argosy Casino Hotel & Spa. Penn National intends to commence a search for a new General Manager for Hollywood Casino Baton Rouge.
Penn National Gaming, Inc. and its subsidiaries own and manage gaming and pari-mutuel properties in the United States.
**************************************************************
**************************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).








